Advancements in Personalized Radiation Therapy for Head and Neck Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Therapy".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 239
Special Issue Editor
Special Issue Information
Dear Colleagues,
We are pleased to announce a call for submissions to a Special Issue of Cancers focusing on "Advancements in Personalized Radiation Therapy for Head and Neck Cancer". Head and neck cancer remains a significant health concern worldwide, causing substantial morbidity and mortality. The aim of this Special Issue is to explore the advancements and challenges in the field of personalized radiation therapy, specifically tailored to address the complexities of head and neck cancer treatment.
Traditionally, non-metastatic head and neck cancers have been managed through various treatment modalities, including surgery, chemotherapy, and radiation therapy. However, the effectiveness of radiation therapy greatly depends on personalized approaches that consider individual patient characteristics, tumor biology, and treatment responses. This Special Issue aims to highlight the latest research and clinical progress in developing personalized radiation therapy strategies for head and neck cancer, with the ultimate goal of improving patient outcomes and reducing treatment-related toxicities.
We invite the submission of original research articles and reviews covering all aspects of personalized radiation therapy for head and neck cancer. Topics of interest include, but are not limited to, novel radiation techniques, biomarkers for treatment response prediction, treatment planning optimization, fractionation schemes, and the integration of radiation therapy with other treatment modalities. All submitted manuscripts will undergo a rigorous peer review process to ensure their scientific rigor and quality.
By gathering cutting-edge research and insights in personalized radiation therapy for head and neck cancer, this Special Issue aims to provide a platform for knowledge exchange, fostering advancements in treatment strategies and ultimately improving the lives of patients affected by this challenging disease.
Dr. Shreerang A. Bhide
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
